| Why carry out this study? |
| Substance use disorders (SUDs) place a heavy cost burden on healthcare systems and society at large. |
| Many barriers to effective treatment of SUDs may be overcome with prescription digital therapeutics (PDTs) delivering evidence-based, FDA-approved treatments to patients via mobile devices. |
| This study evaluated the real-world 6-month impact on healthcare resource utilization (HCRU) in 101 patients with SUDs treated with the reSET® PDT. |
| What was learned from this study? |
| Comparing the 6 months before treatment to the 6 months after treatment with the PDT revealed significant decreases in overall hospital encounters, inpatient stays, partial hospitalizations, and emergency department visits. |
| Reductions in facility-encounter HCRU drove 6-month per-patient cost reductions of $3591 post-treatment compared to pre-treatment. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.